Suppr超能文献

tau 蛋白在神经纤维缠结中的生化和细胞学。

Biochemistry and cell biology of tau protein in neurofibrillary degeneration.

机构信息

Max-Planck Unit for Structural Molecular Biology, c/o DESY, 22607 Hamburg, Germany; DZNE, German Center for Neurodegenerative Diseases, and CAESAR Research Center, 53175 Bonn, Germany.

出版信息

Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006247. doi: 10.1101/cshperspect.a006247.

Abstract

Tau represents the subunit protein of one of the major hallmarks of Alzheimer disease (AD), the neurofibrillary tangles, and is therefore of major interest as an indicator of disease mechanisms. Many of the unusual properties of Tau can be explained by its nature as a natively unfolded protein. Examples are the large number of structural conformations and biochemical modifications (phosphorylation, proteolysis, glycosylation, and others), the multitude of interaction partners (mainly microtubules, but also other cytoskeletal proteins, kinases, and phosphatases, motor proteins, chaperones, and membrane proteins). The pathological aggregation of Tau is counterintuitive, given its high solubility, but can be rationalized by short hydrophobic motifs forming β structures. The aggregation of Tau is toxic in cell and animal models, but can be reversed by suppressing expression or by aggregation inhibitors. This review summarizes some of the structural, biochemical, and cell biological properties of Tau and Tau fibers. Further aspects of Tau as a diagnostic marker and therapeutic target, its involvement in other Tau-based diseases, and its histopathology are covered by other chapters in this volume.

摘要

Tau 代表阿尔茨海默病 (AD) 的主要特征之一——神经纤维缠结的亚单位蛋白,因此作为疾病机制的指标受到极大关注。Tau 的许多异常特性可以通过其天然无规卷曲蛋白的性质来解释。例如,大量的结构构象和生化修饰(磷酸化、蛋白水解、糖基化等),众多的相互作用伙伴(主要是微管,但也有其他细胞骨架蛋白、激酶和磷酸酶、马达蛋白、伴侣蛋白和膜蛋白)。鉴于 Tau 具有高可溶性,其病理性聚集是反直觉的,但可以通过形成 β 结构的短疏水性基序来合理化。在细胞和动物模型中,Tau 的聚集是有毒的,但可以通过抑制表达或聚集抑制剂来逆转。这篇综述总结了 Tau 和 Tau 纤维的一些结构、生化和细胞生物学特性。Tau 作为诊断标志物和治疗靶点的进一步方面、它在其他基于 Tau 的疾病中的参与以及其组织病理学在本卷的其他章节中进行了介绍。

相似文献

1
Biochemistry and cell biology of tau protein in neurofibrillary degeneration.
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006247. doi: 10.1101/cshperspect.a006247.
2
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
J Neural Transm Suppl. 1998;53:169-80. doi: 10.1007/978-3-7091-6467-9_15.
3
Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology.
Neurochem Res. 2011 Aug;36(8):1329-35. doi: 10.1007/s11064-011-0475-5. Epub 2011 Apr 21.
4
Tau pathology in Alzheimer disease and other tauopathies.
Biochim Biophys Acta. 2005 Jan 3;1739(2-3):198-210. doi: 10.1016/j.bbadis.2004.09.008.
5
Mechanisms of tau-induced neurodegeneration.
Acta Neuropathol. 2009 Jul;118(1):53-69. doi: 10.1007/s00401-009-0486-3. Epub 2009 Jan 30.
6
Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
J Huazhong Univ Sci Technolog Med Sci. 2017 Jun;37(3):307-312. doi: 10.1007/s11596-017-1732-x. Epub 2017 Jun 6.
8
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Eur J Neurosci. 2007 Jan;25(1):59-68. doi: 10.1111/j.1460-9568.2006.05226.x.
10
Truncated tau from sporadic Alzheimer's disease suffices to drive neurofibrillary degeneration in vivo.
FEBS Lett. 2006 Jun 26;580(15):3582-8. doi: 10.1016/j.febslet.2006.05.029. Epub 2006 May 22.

引用本文的文献

1
Modified tau leads to neuronal and global ribosome dysfunction in model of tauopathy.
bioRxiv. 2025 Aug 30:2025.08.29.670302. doi: 10.1101/2025.08.29.670302.
5
Spontaneous mammalian models for Alzheimer's disease and dementia.
Brain Commun. 2025 Jul 29;7(4):fcaf287. doi: 10.1093/braincomms/fcaf287. eCollection 2025.
6
Rational Modulation of Liquid-Liquid Phase Separation Offers Novel Ways to Combat Tauopathies.
Int J Mol Sci. 2025 Jul 12;26(14):6709. doi: 10.3390/ijms26146709.
9
Causal relationship between proton pump inhibitors and dementia risk: evidence from a Mendelian randomization study.
Eur Arch Psychiatry Clin Neurosci. 2025 Jun 7. doi: 10.1007/s00406-025-02036-6.

本文引用的文献

1
Fluid biomarkers in Alzheimer disease.
Cold Spring Harb Perspect Med. 2012 Sep 1;2(9):a006221. doi: 10.1101/cshperspect.a006221.
2
Frontotemporal dementia: implications for understanding Alzheimer disease.
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a006254. doi: 10.1101/cshperspect.a006254.
3
Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets.
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006437. doi: 10.1101/cshperspect.a006437.
7
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation.
Nature. 2011 Jun 15;475(7354):96-100. doi: 10.1038/nature10154.
8
The many faces of tau.
Neuron. 2011 May 12;70(3):410-26. doi: 10.1016/j.neuron.2011.04.009.
10
The Hsp90 kinase co-chaperone Cdc37 regulates tau stability and phosphorylation dynamics.
J Biol Chem. 2011 May 13;286(19):16976-83. doi: 10.1074/jbc.M110.182493. Epub 2011 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验